Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

Creatine monohydrate or placebo

Placebo, 2g, 4g, and 10g of creatine monohydrate

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

Perry Renshaw

OTHER

NCT01601210 - Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder | Biotech Hunter | Biotech Hunter